Therapeutic Drug Monitoring of Lopinavir in HIV-infected Children on Second-line Antiretroviral Therapy in Asia

BACKGROUND: Failure rates of second-line boosted protease inhibitor antiretroviral therapy regimens in children rise over time. Therapeutic drug monitoring (TDM) can contribute to assessments of adherence. The authors assessed the performance characteristics of the US DHHS-recommended lopinavir (LPV...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Drug Monit
Päätekijät: Aurpibul, Linda, Teerananchai, Sirinya, Prasitsuebsai, Wasana, Sudjaritruk, Tavitiya, Kosalaraksa, Pope, Kurniati, Nia, Truong, Khanh Huu, Do, Viet Chau, Van Nguyen, Lam, Chokephaibulkit, Kulkanya, Singtoroj, Thida, Kerr, Stephen J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112108/
https://ncbi.nlm.nih.gov/pubmed/27749514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000329
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia